A Trial of the C-TraC Intervention for Dementia Patients

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Completed
CT.gov ID
NCT02388711
Collaborator
National Institute on Aging (NIA) (NIH)
584
1
2
55.4
10.5

Study Details

Study Description

Brief Summary

The goal of the project is to conduct a prospective, randomized-controlled clinical trial to determine the extent to which the Coordinated-Transitional Care (C-TraC) program impacts transitional care quality, patient cognition/function, caregiver stress and 30-day rehospitalizations in patients with documented diagnoses of dementia discharged from the hospital to the community.

Condition or Disease Intervention/Treatment Phase
  • Other: C-TraC Intervention
N/A

Detailed Description

Patients with dementia often experience poor quality transitions from the hospital to the community. In response, the investigators developed and piloted the Coordinated-Transitional Care (C-TraC) program--a low-cost, telephone-based intervention designed to improve care coordination and outcomes in hospitalized patients with dementia or other high-risk conditions discharged to community settings.

A single-blind, prospective, randomized-controlled trial will be used with participants being randomly assigned to receive usual (i.e. standard) care, or usual care plus the C-TraC intervention. Outcomes will be assessed via scheduled phone-calls at 14, 30, and 90 days post-hospitalization. A 45-day phone call will also be conducted to complete a brief satisfaction survey with the caregiver about their post-hospital experience.

Study Design

Study Type:
Interventional
Actual Enrollment :
584 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
A Randomized Control Trial of the Coordinated-Transitional Care (C-TraC) Intervention for Dementia Patients
Study Start Date :
Mar 1, 2015
Actual Primary Completion Date :
Oct 11, 2019
Actual Study Completion Date :
Oct 11, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Usual Care with C-TraC Intervention

Patients/caregivers randomized to this group will receive all routine hospital discharge education/materials (same as usual care group), but will also be enrolled in the C-TraC Program. C-TraC is a low-resource, telephone-based, protocol-driven program designed to reduce 30-day rehospitalizations and to improve care transitions during the early post-hospital period.

Other: C-TraC Intervention
C-TraC utilizes a nurse case manager to coordinate the patient's transitional care through active participation in inpatient multidisciplinary discharge rounds, a single brief protocol-driven inpatient encounter, and 1-4 protocol-driven post-hospital telephone calls with the patient/caregiver using spaced retrieval techniques.

No Intervention: Usual Care

Usual care group patients will receive all routine University of Wisconsin Hospital and Clinics (UWHC) discharge education/materials. This includes pharmacy-led medication teaching, physician discussions and routine nursing education. No post hospital education/contact is performed by these providers. Caregivers are sometimes, but not always, involved. Patients may receive home health services, depending on their physician's discharge plan.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in rehospitalizations at 14, 30 and 90-days [14, 30 and 90-days]

    The presence of any rehospitalization will be assessed through a combination of 14, 30 and 90 day structured phone calls directly to patients/caregivers, a detailed review of medical records associated with any of these caregiver/patient reported rehospitalizations, and a detailed review of the patient's UWHC medical records after all phone calls are completed.

Secondary Outcome Measures

  1. Increase in patient delirium prevention/resolution [14, 30 and 90-days]

    To assess for delirium, the Family Confusion Assessment Method (FAM-CAM) will be used - an 11-item tool designed to detect delirium from the observations of family caregivers.

  2. Patient functional maintenance/recovery [14, 30 and 90-days]

    To assess function, the investigators will use the Alzheimer's Disease Co-operative Study - Activities of Daily Living Inventory (ADCS-ADL). ADCS-ADL is a 23 item tool which offers detailed descriptions of each functional activity and asks caregivers to describe the patient's observed actions or behaviors.

  3. Patient falls prevention [14, 30 and 90-days]

    Caregivers will be asked to report the presence and dates of any patient falls since discharge.

  4. Decrease caregiver stress [14, 30 and 90-days]

    To measure caregiver stress the 22-item Zarit Caregiver Burden Scale and the 6-item Caregiver Activation Survey (CAS) will be used. The Zarit Caregiver Burden Scale is used as a measure of caregiver psychological stress and the CAS is used as a measure of time spent caregiving. The investigators will also assess caregiver stress using the 9-item Patient Health Questionnaire (PHQ-9) and the 3-item Care Transitions Measure (CTM-3). The PHQ-9 is used to establish provisional depressive disorder diagnoses as well as grade the severity of depressive symptoms. The CTM-3 has been modified to be given to caregivers discussing their experience with coordinating their loved ones care after hospital discharge. The statements ask about when the loved one was in the hospital, when they were preparing to leave the hospital and about their medications.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Patient Inclusion Criteria:
  • English-speaking

  • Have a working telephone

  • Hospitalized on medical inpatient wards at UWHC

  • A documented pre-hospitalization diagnosis of dementia.

  • Alzheimer's Disease Cooperative Study - Clinical Dementia Rating (ADCS-CDR) score of > 0

  • Have a family member/informal caregiver who has regular contact with them in the community setting

Caregiver Inclusion Criteria:
  • English-speaking

  • Have a working telephone

  • Have contact with patient a minimum of once per week

Patient Exclusion Criteria:
  • Discharged to institutional settings

  • No identified caregiver

  • Discharged to hospice

  • Followed by complex case management or any form of intensive case management (e.g. transplant, congestive heart failure, dialysis)

  • Score moderate-high on modified ASSIST tool for alcohol

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Wisconsin Hospital Madison Wisconsin United States 53792

Sponsors and Collaborators

  • University of Wisconsin, Madison
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Amy J Kind, MD, PhD, University of Wisconsin - Madison, School of Medicine and Public Health, Department of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT02388711
Other Study ID Numbers:
  • 2014-1221
  • 2P50AG033514-06
  • A534255
  • SMPH\MEDICINE\GER-AD DEV
  • Protocol Version 8/21/2018
First Posted:
Mar 17, 2015
Last Update Posted:
Feb 12, 2021
Last Verified:
Feb 1, 2021
Keywords provided by University of Wisconsin, Madison
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 12, 2021